Forebyggende behandling mod hiv-infektion

Frederik Neess Engsig; Gitte Kronborg

doi:10.61409/V10230672

Forebyggende behandling mod hiv-infektion

Frederik Neess Engsig
, Gitte Kronborg

Infektionsmedicinsk Afdeling AHH

Abstract

Pre-exposure prophylaxis (PrEP) decreases the risk for HIV transmission in high-risk populations. PrEP has been available in Denmark since 2019 and consists of antiretroviral drugs in a combination tablet taken daily or on demand. The effect of this prophylaxis in Denmark is summarized in the review. PrEP is indicated in men and transgender persons with unprotected anal intercourse with multiple male partners in the latest 12 weeks or recent diagnoses of syphilis, chlamydia, or gonorrhoea. PrEP is provided by infectious disease specialists. Continued implementation could significantly reduce HIV transmission and potentially end the epidemic in Denmark.

Bidragets oversatte titel	Pre-exposure prophylaxis against HIV infection
Originalsprog	Dansk
Artikelnummer	V10230672
Tidsskrift	Ugeskrift for Laeger
Vol/bind	186
Udgave nummer	19
Antal sider	6
ISSN	0041-5782
DOI	https://doi.org/10.61409/V10230672
Status	Udgivet - jan. 2024

Emneord

Humans
Pre-Exposure Prophylaxis
HIV Infections/prevention & control
Male
Anti-HIV Agents/administration & dosage
Denmark/epidemiology
Female
Transgender Persons

Adgang til dokumentet

10.61409/V10230672Licens: CC BY-NC-ND

Andre filer og links

Link to publication in Scopus

Citationsformater

@article{b3054199df7347cf9a783d610d219c2b,

title = "Forebyggende behandling mod hiv-infektion",

abstract = "Pre-exposure prophylaxis (PrEP) decreases the risk for HIV transmission in high-risk populations. PrEP has been available in Denmark since 2019 and consists of antiretroviral drugs in a combination tablet taken daily or on demand. The effect of this prophylaxis in Denmark is summarized in the review. PrEP is indicated in men and transgender persons with unprotected anal intercourse with multiple male partners in the latest 12 weeks or recent diagnoses of syphilis, chlamydia, or gonorrhoea. PrEP is provided by infectious disease specialists. Continued implementation could significantly reduce HIV transmission and potentially end the epidemic in Denmark.",

keywords = "Humans, Pre-Exposure Prophylaxis, HIV Infections/prevention \& control, Male, Anti-HIV Agents/administration \& dosage, Denmark/epidemiology, Female, Transgender Persons",

author = "Engsig, \{Frederik Neess\} and Gitte Kronborg",

note = "Published under Open Access CC-BY-NC-BD 4.0. https://creativecommons.org/licenses/by-nc-nd/4.0/.",

year = "2024",

month = jan,

doi = "10.61409/V10230672",

language = "Dansk",

volume = "186",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske L{\ae}geforening",

number = "19",

}

TY - JOUR

T1 - Forebyggende behandling mod hiv-infektion

AU - Engsig, Frederik Neess

AU - Kronborg, Gitte

N1 - Published under Open Access CC-BY-NC-BD 4.0. https://creativecommons.org/licenses/by-nc-nd/4.0/.

PY - 2024/1

Y1 - 2024/1

N2 - Pre-exposure prophylaxis (PrEP) decreases the risk for HIV transmission in high-risk populations. PrEP has been available in Denmark since 2019 and consists of antiretroviral drugs in a combination tablet taken daily or on demand. The effect of this prophylaxis in Denmark is summarized in the review. PrEP is indicated in men and transgender persons with unprotected anal intercourse with multiple male partners in the latest 12 weeks or recent diagnoses of syphilis, chlamydia, or gonorrhoea. PrEP is provided by infectious disease specialists. Continued implementation could significantly reduce HIV transmission and potentially end the epidemic in Denmark.

AB - Pre-exposure prophylaxis (PrEP) decreases the risk for HIV transmission in high-risk populations. PrEP has been available in Denmark since 2019 and consists of antiretroviral drugs in a combination tablet taken daily or on demand. The effect of this prophylaxis in Denmark is summarized in the review. PrEP is indicated in men and transgender persons with unprotected anal intercourse with multiple male partners in the latest 12 weeks or recent diagnoses of syphilis, chlamydia, or gonorrhoea. PrEP is provided by infectious disease specialists. Continued implementation could significantly reduce HIV transmission and potentially end the epidemic in Denmark.

KW - Humans

KW - Pre-Exposure Prophylaxis

KW - HIV Infections/prevention & control

KW - Male

KW - Anti-HIV Agents/administration & dosage

KW - Denmark/epidemiology

KW - Female

KW - Transgender Persons

UR - https://www.scopus.com/pages/publications/85194830430

U2 - 10.61409/V10230672

DO - 10.61409/V10230672

M3 - Review

C2 - 38808765

SN - 0041-5782

VL - 186

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 19

M1 - V10230672

ER -

Forebyggende behandling mod hiv-infektion

Abstract

Emneord

Adgang til dokumentet

Andre filer og links

Fingeraftryk

Citationsformater